» Articles » PMID: 33409911

Anti-aging Effects of Antioxidant Rare-Earth Orthovanadate Nanoparticles in Wistar Rats

Overview
Date 2021 Jan 7
PMID 33409911
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Biomedical application of rare-earth-based nanoparticles attracts much attention due to their unique optical and redox properties and quite low toxicity. Earlier, we found age-related beneficial effects of rare-earth-based orthovanadate nanoparticles (OV NPs) on the prooxidant/antioxidant balance in liver and blood of Wistar rats, as reported by Nikitchenko et al. (Biol Trace Elem Res (2020). https://doi.org/10.1007/s12011-020-02196-7 ). However, the question remained unclear whether OV NPs' redox activity directly defines the protection ability. In the present work, antiradical, antioxidant, and membrane-protective properties of GdYVO/Eu NPs (1-2 nm), GdVO/Eu NPs (8 × 25 nm), LaVO/Eu (57 × 8 nm) were assayed in a comparative manner in various model systems. All OV NPs demonstrated the protective properties, but extra-small GdYVO/Eu NPs revealed the weakest antioxidant efficacy. In isolated mitochondria, OV NPs lowered (most evidently-extra-small NPs) respiration and oxidative phosphorylation, as well as ATP concentration. We conclude that not only the direct antioxidant effect but also slight suppression of bioenergetic processes by the OV NPs as well as the triggering of GSH-dependent antioxidant system may represent the principal mechanisms of their beneficial influences in an aged organism. This statement is consistent with improvement of the oxidative balance of 33-month-old rats due to prolonged administration of GdVO /Eu NPs (for 11 months) accompanied by retention of the GSH signaling of the old rats at the level of 12 months mature animals. Consequently, an increase of antioxidant defense upon prolonged usage of OV NPs will lead to oxidative balance stabilization increasing the health span and survival of an organism.

Citing Articles

Biomedical applications of metal oxide nanoparticles in aging and age-associated diseases.

Yadav S, Maurya P 3 Biotech. 2021; 11(7):338.

PMID: 34221809 PMC: 8208341. DOI: 10.1007/s13205-021-02892-8.


Protective Effect of Biobran/MGN-3 against Sporadic Alzheimer's Disease Mouse Model: Possible Role of Oxidative Stress and Apoptotic Pathways.

Ghoneum M, Sayed N Oxid Med Cell Longev. 2021; 2021:8845064.

PMID: 33574982 PMC: 7857904. DOI: 10.1155/2021/8845064.

References
1.
Harman D . Aging: overview. Ann N Y Acad Sci. 2002; 928:1-21. DOI: 10.1111/j.1749-6632.2001.tb05631.x. View

2.
Rzigalinski B . Nanoparticles and cell longevity. Technol Cancer Res Treat. 2005; 4(6):651-9. DOI: 10.1177/153303460500400609. View

3.
Gai S, Li C, Yang P, Lin J . Recent progress in rare earth micro/nanocrystals: soft chemical synthesis, luminescent properties, and biomedical applications. Chem Rev. 2013; 114(4):2343-89. DOI: 10.1021/cr4001594. View

4.
Abdesselem M, Schoeffel M, Maurin I, Ramodiharilafy R, Autret G, Clement O . Multifunctional rare-Earth vanadate nanoparticles: luminescent labels, oxidant sensors, and MRI contrast agents. ACS Nano. 2014; 8(11):11126-37. DOI: 10.1021/nn504170x. View

5.
Tkachenko A, Klochkov V, Lesovoy V, Myasoedov V, Kavok N, Onishchenko A . Orally administered gadolinium orthovanadate GdVO:Eu nanoparticles do not affect the hydrophobic region of cell membranes of leukocytes. Wien Med Wochenschr. 2020; 170(7-8):189-195. DOI: 10.1007/s10354-020-00735-4. View